MedTrace Logo

The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency Coupling

NCT06605300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-10-03

No results posted yet for this study

Summary

The main aim of the study is to investigate whether intranasal oxytocin and vasopressin have effects on delta-beta cross-frequency coupling under resting-state and task conditions.

Conditions

  • Healthy

Interventions

DRUG

Intranasal Oxytocin (IN-OXT)

Subject assigned to receive intranasal administration of oxytocin (24 IU).

DRUG

Intranasal Vasopressin (AVP)

Subjects assigned to receive intranasal administration of vasopressin (20 IU).

DRUG

Intranasal Placebo

Subjects assigned to receive intranasal administration of placebo.

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Shuxia Yao, Dr · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-02
Primary Completion
2025-07-28
Completion
2025-08-12

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06605300 on ClinicalTrials.gov